Cargando…

Immune Response to Invasive Group B Streptococcus Disease in Adults

Immunization of nonpregnant adults could help prevent invasive group B Streptococcus (GBS) infections, but adult immune responses have not been investigated. We defined capsular polysaccharide (CPS) and pilus island (PI) surface antigen distribution and expression and immune responses to GBS infecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Edwards, Morven S., Rench, Marcia A., Rinaudo, C. Daniela, Fabbrini, Monica, Tuscano, Giovanna, Buffi, Giada, Bartolini, Erika, Bonacci, Stefano, Baker, Carol J., Margarit, Immaculada
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088039/ https://www.ncbi.nlm.nih.gov/pubmed/27767008 http://dx.doi.org/10.3201/eid2211.160914

Ejemplares similares

Novel Multiplex Immunoassays for Quantification of IgG against Group B Streptococcus Capsular Polysaccharides in Human Sera
por: Buffi, Giada, et al.
Publicado: (2019)

Contribution of pilus type 2b to invasive disease caused by a Streptococcus agalactiae ST-17 strain
por: Lazzarin, Maddalena, et al.
Publicado: (2017)

Proof of concept for a single-dose Group B Streptococcus vaccine based on capsular polysaccharide conjugated to Qβ virus-like particles
por: Carboni, Filippo, et al.
Publicado: (2023)

Serotype IV Streptococcus agalactiae ST-452 has arisen from large genomic recombination events between CC23 and the hypervirulent CC17 lineages
por: Campisi, Edmondo, et al.
Publicado: (2016)

Evolving Antibiotic Resistance in Group B Streptococci Causing Invasive Infant Disease: 1970 – 2021
por: Sabroske, Elizabeth Marie, et al.
Publicado: (2023)

Structure and Assembly of Group B Streptococcus Pilus 2b Backbone Protein
por: Cozzi, Roberta, et al.
Publicado: (2015)

The Streptococcus agalactiae complement interfering protein combines multiple complement-inhibitory mechanisms by interacting with both C4 and C3 ligands
por: Giussani, Stefania, et al.
Publicado: (2019)

Group B Streptococcus chimeric capsular polysaccharides as novel multivalent vaccine candidates
por: Campisi, Edmondo, et al.
Publicado: (2021)

Targeted Amino Acid Substitutions Impair Streptolysin O Toxicity and Group A Streptococcus Virulence
por: Chiarot, Emiliano, et al.
Publicado: (2013)

Safety and Immunogenicity of a Second Dose of an Investigational Maternal Trivalent Group B Streptococcus Vaccine in Nonpregnant Women 4–6 Years After a First Dose: Results From a Phase 2 Trial
por: Leroux-Roels, Geert, et al.
Publicado: (2020)

Biofilm formation by Streptococcus agalactiae: influence of environmental conditions and implicated virulence factors
por: Rosini, Roberto, et al.
Publicado: (2015)

Chemical Synthesis and Immunological Evaluation of Fragments of the Multiantennary Group-Specific Polysaccharide of Group B Streptococcus
por: Wang, Zhen, et al.
Publicado: (2022)

Mice repeatedly exposed to Group-A β-Haemolytic Streptococcus show perseverative behaviors, impaired sensorimotor gating, and immune activation in rostral diencephalon
por: Macrì, Simone, et al.
Publicado: (2015)

Protective effect of Group B Streptococcus type-III polysaccharide conjugates against maternal colonization, ascending infection and neonatal transmission in rodent models
por: Chiarot, Emiliano, et al.
Publicado: (2018)

125 Single Nucleotide Polymorphisms Drive Phenotypic Diversity Among Sequence Type 1 Group B Streptococcus, An Emerging Cause of Invasive Disease in Adult Humans
por: Galloway-Pena, Jessica, et al.
Publicado: (2014)

Publisher Correction: Mice repeatedly exposed to Group-A β-Haemolytic Streptococcus show perseverative behaviors, impaired sensorimotor gating, and immune activation in rostral diencephalon
por: Macrì, Simone, et al.
Publicado: (2020)

Genomic Analysis Reveals the Molecular Basis for Capsule Loss in the Group B Streptococcus Population
por: Rosini, Roberto, et al.
Publicado: (2015)

Genomic Analysis Reveals Multi-Drug Resistance Clusters in Group B Streptococcus CC17 Hypervirulent Isolates Causing Neonatal Invasive Disease in Southern Mainland China
por: Campisi, Edmondo, et al.
Publicado: (2016)

Neonatal corticosterone mitigates autoimmune neuropsychiatric disorders associated with streptococcus in mice
por: Macrì, Simone, et al.
Publicado: (2018)

Maternal vaccination with a type-III glycoconjugate protects mouse neonates against Group B Streptococcus intranasal infection
por: Chiarot, Emiliano, et al.
Publicado: (2021)

Emergence and Global Dissemination of Host-Specific Streptococcus agalactiae Clones
por: Sørensen, Uffe B. Skov, et al.
Publicado: (2010)

Multi High-Throughput Approach for Highly Selective Identification of Vaccine Candidates: the Group A Streptococcus Case
por: Bensi, Giuliano, et al.
Publicado: (2012)

Neonatal invasive disease caused by Streptococcus agalactiae in Europe: the DEVANI multi-center study
por: Lohrmann, Florens, et al.
Publicado: (2022)

855. Evolution of Group B Streptococcal Capsular Type V Invasive Infections in Neonates and Young Infants: A Whole Genome Sequencing Study
por: Flores, Anthony R, et al.
Publicado: (2019)

Analysis of Two-Component Systems in Group B Streptococcus Shows That RgfAC and the Novel FspSR Modulate Virulence and Bacterial Fitness
por: Faralla, Cristina, et al.
Publicado: (2014)

971 Clinical Spectrum of Group B Streptococcol Cellulitis-Adenitis Syndrome
por: Pretorius, Christopher C., et al.
Publicado: (2014)

Structure‐Guided Design of a Group B Streptococcus Type III Synthetic Glycan–Conjugate Vaccine
por: Oldrini, Davide, et al.
Publicado: (2020)

Streptococcus pyogenes SpyCEP Influences Host-Pathogen Interactions during Infection in a Murine Air Pouch Model
por: Chiappini, Nico, et al.
Publicado: (2012)

Fighting Antibiotic-Resistant Klebsiella pneumoniae with “Sweet” Immune Targets
por: Adamo, Roberto, et al.
Publicado: (2018)

1483. Maternal Tdap Vaccination During Pregnancy and Immune Response: A Comparison Between Infants Born to Mothers Primed with Acellular or Whole Cell Pertussis Vaccines
por: Havers, Fiona, et al.
Publicado: (2020)

Protein Array Profiling of Tic Patient Sera Reveals a Broad Range and Enhanced Immune Response against Group A Streptococcus Antigens
por: Bombaci, Mauro, et al.
Publicado: (2009)

Specific Involvement of Pilus Type 2a in Biofilm Formation in Group B Streptococcus
por: Rinaudo, Cira Daniela, et al.
Publicado: (2010)

Structural Basis for Group B Streptococcus Pilus 1 Sortases C Regulation and Specificity
por: Cozzi, Roberta, et al.
Publicado: (2012)

2902. Pertussis Antibody Levels in Preterm Infants After Maternal Tdap Immunization During Pregnancy
por: Healy, C Mary, et al.
Publicado: (2019)

Use of whole-genome sequencing to detect transmission of group A Streptococcus in Houston, TX
por: Alamarat, Zain I., et al.
Publicado: (2022)

Understanding the Molecular Determinants Driving the Immunological Specificity of the Protective Pilus 2a Backbone Protein of Group B Streptococcus
por: Nuccitelli, Annalisa, et al.
Publicado: (2013)

Group A Streptococcus
por: Hand, Robert M., et al.
Publicado: (2020)

Group A Streptococcus
por: Snelling, Thomas L, et al.
Publicado: (2013)

Hospital acquired invasive group A streptococcus infections
por: Erbay, Ayse
Publicado: (2014)

1625. Risk of Invasive Group A Streptococcus, Group B Streptococcus, and Streptococcus pneumoniae Infection Among Adults Experiencing Homelessness—Anchorage, Alaska, 2002–2015
por: Mosites, Emily, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_h9ug34m5og53uhbd8h597736bl